Ureteroneocystostomy for Cats: Low Complication Rates Study

Ureteroneocystostomy: A Primary Surgical Option with Low Complication Rates

A common and serious urinary condition in cats is ureteral obstruction, where a blockage prevents urine from flowing from the kidney to the bladder. Historically, managing this condition has involved complex decisions between different surgical implants and traditional techniques. A new, large-scale study from a team of Japanese researchers, including K. Oyamada from Matsubara Animal Hospital and M. Fujiki from Kagoshima University, provides strong evidence for one specific surgical approach. Their work, published in the Journal of the American Veterinary Medical Association, reviewed 189 cats treated between 2018 and 2024 and found that a tailored ureteroneocystostomy—surgically reconnecting the ureter directly to the bladder—can be a primary and highly successful treatment.

Low Mortality and High Survival with Refined Surgical Technique

The research analyzed outcomes for 220 ureters in 189 cats that underwent ureteroneocystostomy for benign obstructions. The overall results were notable: a perioperative mortality rate of just 0.5% and a one-year survival rate of 89.4%. These figures compare favorably to outcomes previously reported for alternative treatments like subcutaneous ureteral bypass (SUB) systems or ureteral stents.

Mechanically, the surgery bypasses the obstructed segment of the ureter by creating a new connection between the healthy upper part of the tube and the bladder wall. The study highlighted that the specific technique matters greatly. The “extravesicular, 2-layer, side-to-side” method, combined with “tension-relieving techniques,” proved most effective at reducing the risk of reobstruction. Simply put, this meticulous approach ensures the new connection is secure and under no physical strain, preventing scar tissue or kinks from forming and blocking urine flow again.

Complications: UTI Risk and the Impact of Pre-Existing Kidney Disease

While the surgery was largely successful, the study did quantify important risks. The rate of postoperative urinary tract infection (UTI) was 13.2%. This infection risk stems from the surgical manipulation of the urinary tract and the introduction of a temporary catheter, which can allow bacteria to ascend. Managing this risk requires vigilant postoperative care, including possible antibiotic use guided by urine culture, as outlined in our article on Cat UTI Prevention Tips Beating Superbugs for Healthy Pets.

Another critical finding was the powerful influence of a cat’s kidney health prior to surgery. Cats classified as International Renal Interest Society (IRIS) chronic kidney disease (CKD) stage III or higher one month after surgery had significantly shorter survival times. This underscores that while the surgery effectively relieves the acute obstruction, the long-term prognosis is heavily dependent on the extent of permanent kidney damage that occurred before the procedure.

Rare but Serious: When Obstruction Points to Cancer

The majority of ureteral obstructions in cats are benign, often caused by microscopic mineral plugs or fibrous tissue. However, a separate case report in the Journal of Comparative Pathology serves as a crucial reminder that obstructions can have a malignant origin. Researchers from Universidade Federal do Rio Grande do Sul documented a rare retroperitoneal T-cell lymphoma in a young, FeLV-positive cat. The tumor mass caused both urethral obstruction and megacolon.

This case illustrates a different pathological mechanism: cancerous cells proliferate in the space behind the abdominal cavity, forming a mass that physically compresses and invades the ureters and colon. It highlights the necessity of a thorough diagnostic workup, including imaging and sometimes biopsy, to distinguish between a benign obstruction and a neoplastic one before deciding on a surgical plan.

Practical Implications for Cat Owners and Veterinarians

For veterinarians, this research solidifies tailored ureteroneocystostomy as a primary, rather than a last-resort, surgical option for benign ureteral obstruction. The data supports its use alongside or in preference to implant-based systems in many cases, depending on surgical expertise and the patient’s anatomy. The emphasis on tension-relieving techniques is a specific, actionable insight from the operative field.

For cat owners, the findings offer realistic expectations. The surgery carries a very high chance of short-term survival and excellent long-term outcomes for a year, especially if kidney disease is not advanced. Awareness of the potential for postoperative UTIs means owners should watch for signs like frequent, painful urination or blood in the urine after surgery and report them promptly. Furthermore, managing underlying CKD in cats remains a parallel and vital component of care, as it is a major determinant of ultimate survival.

Frequently Asked Questions

Is ureteroneocystostomy a new procedure for cats?

No, it is an established surgical technique. The new evidence from Oyamada and colleagues confirms it is highly effective with low complication rates when performed with specific refinements like tension-relieving methods.

What are the signs that my cat might have a ureteral obstruction?

Cats may show signs of acute kidney injury, including lethargy, loss of appetite, vomiting, and decreased urine production. Often, there are no specific signs related to urination itself, making it a silent and dangerous condition that requires prompt veterinary diagnosis.

My cat has CKD and a ureteral obstruction. Is surgery still an option?

Yes, surgery is often still recommended to relieve the obstruction and preserve remaining kidney function. However, the study clearly shows that cats with more advanced CKD (IRIS stage III or higher) have a more guarded long-term prognosis, which should be discussed with your veterinarian.

How common are urinary tract infections after this surgery?

The study found a postoperative UTI rate of 13.2%. This is a known risk with any urinary tract surgery, and managing it involves careful monitoring and potential antibiotic treatment based on follow-up urine tests.

Sources:
https://pubmed.ncbi.nlm.nih.gov/41849815/
https://pubmed.ncbi.nlm.nih.gov/41259928/
https://pubmed.ncbi.nlm.nih.gov/41035374/